LightPath Technologies, Inc. — Form 10-K Summary
Reporting period: Fiscal year ended June 30, 2020, with fiscal 2019 as the comparable period. Although the request references “2019 Q4,” this filing reports fiscal 2020; fourth-quarter results are included below where available.
Business context
LightPath designs, manufactures, and sells precision molded optics, infrared optics, and specialty optical products and assemblies. Its facilities and operations span the United States, China, and Latvia. Infrared products were the largest product group in fiscal 2020, at about 52% of revenue, followed by precision molded optics at 42% and specialty products at 6%.
Financial performance and liquidity
| Metric | FY2020 | FY2019 |
|---|---|---|
| Revenue | $35.0 million | $33.7 million |
| Gross margin | $13.8 million; 39.6% of revenue | $12.5 million; 37.1% of revenue |
| Operating income (loss) | $2.1 million | $(1.1) million |
| Net income (loss) | $0.87 million; $0.03 diluted EPS | $(2.68) million; $(0.10) diluted EPS |
| EBITDA, non-GAAP | $5.4 million; 15% of revenue | $1.9 million; 6% of revenue |
| Cash provided by operations | $3.7 million | $0.4 million |
| Capital expenditures | $2.4 million | $1.9 million |
- Fiscal 2020 revenue grew 4%. Infrared revenue rose 5% to $18.1 million and molded optics revenue rose 4% to $14.6 million; specialty revenue declined 4% to $2.3 million.
- At June 30, 2020, cash and cash equivalents were $5.4 million, working capital was approximately $13.9 million, and total assets were $47.6 million. More than half of cash was held by foreign subsidiaries.
- Loans payable were approximately $5.4 million net of unamortized debt costs: about $5.1 million outstanding on the term loan and $0.4 million on the revolving line. No borrowings were outstanding under the $10 million guidance line. The company reported compliance with loan covenants.
- Three customers accounted for approximately 31% of fiscal 2020 revenue. Foreign sales represented 66% of revenue.
- Fourth-quarter revenue was $9.1 million, up 4% year over year; net income was $657,000, compared with a $1.76 million loss in the prior-year quarter.
Material changes versus fiscal 2019
- The company returned to profitability, reporting $0.87 million of net income versus a $2.68 million net loss. Management attributed the turnaround mainly to higher revenue and gross margin, lower operating costs, and reduced interest expense.
- Gross margin improved by about 2.5 percentage points. Management cited improved BD6 production yields, mitigation of tariff and freight costs, and a more favorable cost structure after relocating the former Irvington operations.
- SG&A fell 15% to $9.0 million, in part because fiscal 2019 included approximately $1.2 million in relocation-related costs. New product development costs declined to $1.7 million from $2.0 million.
- Operating cash flow increased to $3.7 million. Inventory rose to $9.0 million from $7.7 million, and average days cost of sales in inventory increased to 132 from 116.
- Revenue mix shifted toward higher unit volumes and lower average selling prices in molded optics and infrared products. Unit volumes rose 40% for molded optics and 66% for infrared products for the year.
Outlook, commentary, and risks
- Management anticipated revenue growth in fiscal 2021, based on backlog and quote activity, including growth in molded and turned infrared products and visible molded optics. Twelve-month backlog was $19.1 million at June 30, 2020, up 11% year over year.
- Management expected fiscal 2021 capital expenditures to be at a similar level to fiscal 2020, subject to sales opportunities and circumstances. It also expected to pursue growth in infrared products, including BD6, and continue investment in customer-specific solutions and core technologies.
- The company said it had not experienced a direct COVID-19 business impact as of the filing, but warned that pandemic-related economic effects could reduce customer demand and adversely affect operations, cash flows, and liquidity; fiscal 2021 effects could not be estimated.
- Principal risks include customer concentration, international operations and foreign-currency exposure, U.S.-China tariffs and trade actions, dependence on limited-source suppliers, competition and pricing pressure, manufacturing yields and capacity, and the ability to commercialize new products. The company has a history of losses and an accumulated deficit of approximately $197.1 million.
- China cash repatriation is subject to restrictions and withholding taxes. The company repatriated approximately $2 million from its Chinese subsidiary in fiscal 2020 and declared a further $3 million dividend after year-end, with $300,000 of expected withholding taxes.
- The company reported no current material legal proceedings. Management concluded disclosure controls and internal control over financial reporting were effective; the independent auditor did not attest to internal control effectiveness.
Important facts for investors to verify
- Confirm that fiscal 2020 results and the June 30 year-end—not a fiscal 2019 fourth-quarter filing—match the intended reporting period.
- Track whether backlog converts into revenue and whether demand for BD6 and temperature-sensing products persists beyond pandemic-related applications.
- Assess whether gross-margin gains, production yields, and cost reductions are sustainable amid pricing pressure, tariffs, and changing product mix.
- Review debt repayment and refinancing terms, covenant headroom, and the availability and location of cash, including restrictions on repatriation.
- Monitor customer concentration, receivable collection, and inventory growth; verify the effects of COVID-19 and international trade conditions on orders and supply.